Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

HIV can cause various nail and hair disorders, important for early diagnosis and treatment.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

Platelet-rich plasma therapy helps improve atrophic acne scars.

Plasma is better than Ringer's lactate for hair graft survival and growth after transplantation.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

Platelet-rich plasma (PRP) significantly improves long-lasting post-viral smell dysfunction.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Google should ban ads targeting cancer patients with sensitive health-related keywords to protect them from misleading information.

Fasting may reduce chemotherapy side effects.

Additive markers are most common and crucial for text coherence.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Minoxidil boosts growth factor in hair cells, potentially promoting hair growth.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.

Icariin helps mouse hair grow by boosting a growth factor in skin cells.

Severe digestive issues in DRESS need early endoscopy for better treatment.